Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 July 2020 | Story Igno van Niekerk | Photo Igno van Niekerk
Keabetswe Malebo was recipient to the scholarship by Abbe Levin.

Great stories are often the result of unexpected connections made across time and space. Upon looking back and connecting dots, one is often surprised at how seemingly random events lead to happy endings, which in themselves become beginnings for new stories.

Leaving a legacy

When Ida Manana Siyila left South Africa in the first half of the twentieth century, no one would have known how her legacy would influence a young student at the UFS many years later. While working for the same American family for more than 30 years, she never stopped learning and working to improve herself. Ida, proud of her dual citizenship, never lost contact with her friends and family in Bloemfontein, wishing to return to Bloemfontein in her old age. Her American family made sure that this wish was fulfilled.

For Keabetswe Malebo, the first six months as a student were tough. An energetic young lady with joy in her voice and a passion for learning and making a difference in her community, Keabetswe had been squatting with a friend while studying at the UFS. The friend was running out of money; there was no way Keabetswe could pay her debt, and her friend could not afford the rent. No rent, no accommodation. No accommodation, no further studies.

Changing a life

Abbe Levin was sincerely grateful for what Ida Siyila had done for her family. In 2017, Abbe made a donation to the UFS requesting that it be used as a scholarship for a disadvantaged student in Ida’s name.

When Keabetswe read about the scholarship, she applied. “I felt it was for me, I was so excited and afraid.” Keabetswe’ s belief, commitment, and hard work were rewarded when she was granted the scholarship. “I got the money just in time to buy a laptop, a printer, and a microwave … and of course to pay the rent I owed my friend.”

Since then, Keabetswe has met Abbe Levin online, and they have become friends, communicating, sharing family pictures and stories, ever grateful for the never-ending story of Ida Manana Siyila.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept